![Philip Jull](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Jull
Vorstandsvorsitzender bei
RIZE ONCOLOGY INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Philip Gage Jull was the founder of Bordeaux Capital, Inc., founded in 2015, where the title held was Chairman from 2015 to 2022.
Current jobs include Chief Executive Officer & Director at Rize Oncology, Inc. starting in 2025; Executive Chairman at Arrow Exploration Corp.
since 2020; Executive Chairman at Euromax Resources Ltd. starting in 2026; Director at GeneTether, Inc.; and Non-Executive Director at Entropy Neurodynamics Ltd. since 2020.
Former jobs include Managing Director-Corporate Finance at Research Capital Corp.
from 2004 to 2015; Independent Director at Aldridge Minerals, Inc.; and Independent Director at Tryp Therapeutics, Inc. from 2020 to 2024.
Education includes undergraduate studies at the University of Toronto and an MBA from the University of Western Ontario.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARROW EXPLORATION CORP. 2,54 % | 23.03.2026 | 7.248.508 ( 2,54 % ) | 2 Mio $ | 31.05.2026 |
RIZE ONCOLOGY INC. 0,2 % | 10.11.2025 | 148.919 ( 0,2 % ) | 2 155 $ | 30.04.2025 |
| 02.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Philip Jull
| Unternehmen | Position | Beginn |
|---|---|---|
| ARROW EXPLORATION CORP. | Vorsitzender | 21.03.2020 |
| RIZE ONCOLOGY INC. | Vorstandsvorsitzender | 16.10.2025 |
| EUROMAX RESOURCES LTD. | Vorsitzender | 05.01.2026 |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene editing technologies intended for human therapeutic applications | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Philip Jull
| Unternehmen | Position | Ende |
|---|---|---|
Tryp Therapeutics, Inc.
 Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Vorsitzender | 01.05.2024 |
Bordeaux Capital, Inc.
 Bordeaux Capital, Inc. Investment ManagersFinance Provides investment advisory services | Gründer | 01.01.2022 |
Research Capital Corp.
 Research Capital Corp. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.11.2015 |
| ALDRIDGE MINERALS INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Philip Jull
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Euromax Resources Ltd.
 Euromax Resources Ltd. Precious MetalsNon-Energy Minerals Engages in the identification, acquisition and development of mineral resources | Non-Energy Minerals |
Aldridge Minerals, Inc.
 Aldridge Minerals, Inc. Precious MetalsNon-Energy Minerals Explores and mines for gold, copper, lead and zinc concentrates | Non-Energy Minerals |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Capital Corp.
Research Capital Corp. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bordeaux Capital, Inc.
Bordeaux Capital, Inc. Investment ManagersFinance Provides investment advisory services | Finance |
Arrow Exploration Corp.
 Arrow Exploration Corp. Oil & Gas ProductionEnergy Minerals Produces and explores oil and natural gas | Energy Minerals |
Tryp Therapeutics, Inc.
Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene editing technologies intended for human therapeutic applications | Commercial Services |
GeneTether Therapeutics, Inc.
 GeneTether Therapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapies and platform | Health Technology |
